Can Clinically Node-Negative Breast Cancer Patients with Suspicious Axillary Lymph Nodes at Ultrasound But Negative Fine-Needle Aspiration Be Approached as Having Node-Negative Disease?

Coates AS(2015)Tailoring therapies: improving the management of early breast cancer: St Gallen international expert consensus on the primary therapy of early breast cancer 2015 Ann Oncol. 26 1533-1546

Winer EP(2015)Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up Ann Oncol. 26 v8-v30

Goldhirsch A(2011)Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial JAMA. 305 569-575

Senkus E(2016)Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trial Ann Surg. 264 413-420

Kyriakides S(2014)Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update J Clin Oncol. 32 1365-1383

Ohno S(2012)A 10-year trend analysis of sentinel lymph node frozen section and completion axillary dissection for breast cancer: are these procedures becoming obsolete? Ann Surg Oncol. 19 225-232

Giuliano AE(2016)Axillary staging of early-stage invasive breast cancer by ultrasound-guided fine-needle aspiration cytology: which ultrasound criteria for classifying abnormal lymph nodes should be adopted in the post-ACOSOG Z0011 trial era? J Ultrasound Med. 35 885-893

Hunt KK(2013)Influence of tumor histology on preoperative staging accuracy of breast metastases to the axilla Breast J. 19 49-55

Ballman KV(2010)American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer J Clin Oncol. 28 2784-2795

Giuliano AE(2013)Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update J Clin Oncol. 31 3997-4013

Coates AS(2015)Tailoring therapies: improving the management of early breast cancer: St Gallen international expert consensus on the primary therapy of early breast cancer 2015 Ann Oncol. 26 1533-1546

Winer EP(2015)Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up Ann Oncol. 26 v8-v30

Goldhirsch A(2011)Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial JAMA. 305 569-575

Senkus E(2016)Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trial Ann Surg. 264 413-420

Kyriakides S(2014)Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update J Clin Oncol. 32 1365-1383

Ohno S(2012)A 10-year trend analysis of sentinel lymph node frozen section and completion axillary dissection for breast cancer: are these procedures becoming obsolete? Ann Surg Oncol. 19 225-232

Giuliano AE(2016)Axillary staging of early-stage invasive breast cancer by ultrasound-guided fine-needle aspiration cytology: which ultrasound criteria for classifying abnormal lymph nodes should be adopted in the post-ACOSOG Z0011 trial era? J Ultrasound Med. 35 885-893

Hunt KK(2013)Influence of tumor histology on preoperative staging accuracy of breast metastases to the axilla Breast J. 19 49-55

Ballman KV(2010)American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer J Clin Oncol. 28 2784-2795

Giuliano AE(2013)Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update J Clin Oncol. 31 3997-4013